共 426 条
[1]
Cornford P(2017)EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer Eur Urol 71 630-642
[2]
Bellmunt J(2021)EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer Eur Urol 79 263-282
[3]
Bolla M(2005)Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 433-439
[4]
Briers E(2006)Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer Urology 68 593-598
[5]
De Santis M(2008)A nomogram predicting long-term biochemical recurrence after radical prostatectomy Cancer 112 1254-1263
[6]
Gross T(2018)68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis Eur Urol Focus 4 686-693
[7]
Henry AM(2020)Imaging biochemical recurrence after prostatectomy: where are we headed? AJR Am J Roentgenol 214 1248-1258
[8]
Joniau S(2017)Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients Eur J Nucl Med Mol Imaging 44 1258-1268
[9]
Lam TB(2015)Evaluation of hybrid J Nucl Med 56 668-674
[10]
Mason MD(2019)Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy Prostate 79 1514-1522